Europe Archives - Page 62 of 93 - Journal for Clinical Studies

Current Edition

Europe

Anavex Life Sciences Receives Approval To Initiate Phase 2b/3 Clinical Trial of ANAVEX®2-73 for the Treatment of Early Alzheimer’s Disease

ANAVEX®2-73 Being Studied as Potential First Precision Medicine Biomarker-guided, Targeted Therapeutic in Alzheimer’s Disease Primary and Secondary Endpoints mea...

4 July 2018 Europe | North America anavex | approval

Continue Reading →

Europe

VarmX Raises € 12.5 Million to Develop Modified Blood Coagulation Factor X for Treating Severe Bleeding in Patients Using Anti-Coagulants Funding enables clinical stage trials of lead compound PseudoXa

€ 7.5 million Series A financing from lead investor BioGeneration Ventures (BGV) and Dutch regional development company InnovationQuarter Financing supplemente...

4 July 2018 Europe 12.5M | blood

Continue Reading →

Europe

Tecentriq extends streak with win in breast cancer trial

Roche's checkpoint inhibitor Tecentriq helped extend progression-free survival in a Phase 3 study of patients with a hard-to-treat form of metastatic breast cancer...

4 July 2018 Europe | news breast | cancer

Continue Reading →

Australasia

First Volunteers Dosed in Phase I Clinical Trial of PBT434, Prana’s Lead Therapy for Parkinsonian Diseases

Prana enrols and doses its first cohort of healthy volunteers in its Phase I clinical trial Evidence supports activity of PBT434 to prevent α-synuclein accumulat...

4 July 2018 Australasia | Europe | North America clinical | dosed

Continue Reading →

Europe

NIH Opening First Mesothelioma Clinical Trial for Lynparza

The National Institutes of Health (NIH) in Bethesda, Maryland, is opening the first mesothelioma clinical trial involving the immunotherapy drug Lynparza (olaparib), ...

27 June 2018 Europe clinical | first

Continue Reading →

Europe

Medicare should ‘pay it forward’ on clinical trials

“Innovation,” particularly in health, is a policy buzzword these days. Former House Speaker, Newt Gingrich, penned an opinion piece over the weekend that called on Re...

27 June 2018 Europe | North America | Uncategorized clinical | forward

Continue Reading →

Europe

Lilly to Present Phase 3 Data at AHS 2018 Highlighting Innovative Potential Treatments for Migraine and Cluster Headache

Eli Lilly and Company (NYSE: LLY) announced today it will present Phase 3 data for galcanezumab and lasmiditan, two investigational, non-opioid treatments for migra...

27 June 2018 Europe 2018 | AHS

Continue Reading →

Europe

Summit Therapeutics says PhaseOut DMD clinical trial did not meet primary endpoint

The AIM-listed pharmaceuticals group said that because of the outcome, it is discontinuing its development of ezutromid and as a result, will be implementing cost red...

27 June 2018 Europe clinical | DMD

Continue Reading →

Europe

Significant blood sugar improvement with Xultophy® compared to insulin glargine U-100 when used as add-on to oral diabetes medications

Adults with type 2 diabetes treated with Xultophy® (insulin degludec and liraglutide injection) also experienced no change in body weight, lower rates of hypoglycaem...

27 June 2018 Europe blood | compared

Continue Reading →

Europe

Ozempic® provided greater weight reductions for adults with a baseline BMI of or above 25 kg/m2 than those with lower baseline BMI

Ozempic® (semaglutide) 0.5 mg or 1.0 mg provided greater weight reductions vs dulaglutide 0.75 mg or 1.5 mg, respectively, in adults with type 2 diabetes, regardless ...

27 June 2018 Europe adults | BMI

Continue Reading →